Houlihan Lokey, Inc. HLI

129.07 1.58 1.24% as of 25 Sep
Market cap
$8.9B
P/E
21.2×
Growth Flags show if company had growth for consecutive years,
Insider Buys alert about insiders buying in the last 12 month

Insider Decisions

Total buys 0.50
Total sells 2.09
in millions of $
Nov 25 Feb 26 May 26 Aug 26
Buy — — — — — — — — — — 1 —
Sell — — — 1 1 — 1 1 — — — 1
Insider Ownership 18.69%

Capital & Financial Ratios

Market Cap 8,880.00
Revenue 2,523.52
Net Income 404.17
Free Cash Flow 484.82
Net Debt (745.00)
Current Ratio 1.36
Debt/Equity 0.00
P/E ratio 21.19
P/S ratio 3.40
P/B ratio 3.81
Past 5Y EPS Growth 15.80%
This Y EPS Growth (8.25%)
Next Y EPS Growth 25.22%
Next 5Y EPS Growth 8.61%
in millions of $

Dividends

Payout Ratio 0.59
Annual Dividend Rate 2.20
Annual Dividend Yield 1.76%
total individual payouts
2029 Powerpack
2028 Powerpack
2027 Powerpack
2026 2.40
0.60
0.70
0.70
2025 2.37
0.57
0.60
0.60
0.60
2024 2.26
0.55
0.57
0.57
0.57
2023 2.18
0.53
0.55
0.55
0.55
2022 2.02
0.43
0.53
0.53
0.53
2021 1.62
0.33
0.43
0.43
0.43
2020 1.28
0.31
0.31
0.33
0.33
2019 1.20
0.27
0.31
0.31
0.31
2018 1.01
0.20
0.27
0.27
0.27
2017 0.80
0.20
0.20
0.20
0.20
2016 0.66
0.15
0.17
0.17
0.17
predictions in italic, special payouts not included in total or ratios

Assets vs Liabilities

2024 2025 2026 Q'26
Cash 722 971 1,189 745
Receivables 232 257 228 224
Inventory — — — —
Other — — — —
954 1,228 1,418 969
2024 2025 2026 Q'26
Payables 114 137 136 122
ST’ Debt — — — —
Other — — — —
840 1,074 1,213 711
in millions of $

Compound Annual Growth

10y 5y 3y
Sales 14.20% 11.40% 13.10%
Cash Flow 50.62% 3.96% 72.88%
Earnings 19.83% 6.36% 18.75%
Book Value 13.66% 11.10% 13.24%

Revenue

Jun Sep Dec Mar Year
’26 511 — — — —
’26 605 659 717 636 2,618
’25 514 575 634 666 2,389
’24 416 467 511 520 1,914
’23 419 490 456 445 1,809
’22 373 537 889 471 2,270
’21 211 276 538 501 1,525
in millions of $ · fiscal quarters ending in the months shown

Operating Cash Flow

Jun Sep Dec Mar Year
’26 (336) — — — —
’26 (132) 325 218 293 704
’25 (65) 289 266 358 849
’24 (134) 136 101 225 328
’23 (278) 85 91 238 136
’22 (90) 210 552 64 737
’21 (115) 114 309 273 580
in millions of $ · fiscal quarters ending in the months shown

Free Cash Flow

Jun Sep Dec Mar Year
’26 (342) — — — —
’26 (145) 323 217 287 682
’25 (75) 279 262 344 809
’24 (149) 113 85 213 262
’23 (283) 72 77 219 86
’22 (91) 209 547 63 728
’21 (119) 111 304 270 566
in millions of $ · fiscal quarters ending in the months shown

EPS

Jun Sep Dec Mar Year
’26 1.15 — — — —
’26 1.42 1.63 1.70 1.47 6.22
’25 1.30 1.37 1.39 1.76 5.82
’24 0.90 0.99 1.04 1.18 4.11
’23 1.03 0.87 0.90 1.10 3.98
’22 1.25 1.65 2.54 0.97 6.41
’21 0.69 0.70 1.71 1.44 4.55
fiscal quarters ending in the months shown

Target Price Range

Analyst price targets

Recommendation Rating

2.1
1Buy 2 3Hold 4 5Sell
2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029
29.51 34.32 36.25 42.86 63.38 74.18 83.92 112.17 137.99 112.83

Analyst estimates 2027–2029

Powerpack
Low Price
46.99 53.20 50.00 71.00 119.89 122.62 123.51 192.10 211.78 195.06
High Price
1,171 1,228 1,354 1,491 650 839 1,000 1,000 1,100 850
Employees
1 1 1 1 2 3 2 2 2 3
Revenue/Emp
872 963 1,084 1,159 1,525 2,270 1,809 1,914 2,389 2,618
Revenue
30.75% 31.17% 32.23% 32.75% 35.91% 36.95% 35.68% 35.09% 35.78% 35.73%
Gross Margin
178 218 224 236 409 604 324 391 531 562
EBT
20.47% 22.61% 20.69% 20.33% 26.83% 26.61% 17.91% 20.40% 22.24% 21.48%
EBT Margin
108 172 159 184 313 438 254 280 400 424
Net Income
9 8 14 17 15 49 58 29 41 43
Depreciation
14.27 15.42 17.43 18.65 23.19 34.94 28.56 29.76 36.36 39.33
Revenue/Sh
1.77 2.76 2.56 2.96 4.75 6.74 4.25 4.36 6.08 6.40
Earnings/Sh
4.12 4.01 3.60 4.63 8.81 11.34 2.15 5.11 12.91 10.58
Cash Flow/Sh
(0.24) (0.12) (0.11) (0.33) (0.22) (0.13) (0.80) (1.04) (0.60) (0.34)
Capex/Sh
3.89 3.89 3.50 4.30 8.60 11.20 1.35 4.07 12.31 10.25
Free CF/Sh
11.89 13.65 14.33 15.84 21.03 22.22 25.46 28.55 33.09 35.20
Book Value/Sh
61 62 62 62 66 65 63 64 66 67
Shares
19.46 15.82 18.25 17.61 14.06 13.03 21.81 29.39 26.56 22.48
PE Ratio
2.41 2.83 2.68 2.79 2.87 2.51 3.06 4.31 4.44 3.65
PS Ratio
2.90 3.20 3.26 3.29 3.16 3.95 3.44 4.49 4.88 4.08
PB Ratio
1.89 2.53 2.42 2.47 2.31 2.15 2.86 4.14 4.21 3.35
EV/Sales
6.92 10.04 12.09 10.73 6.24 6.69 60.45 30.30 12.42 12.87
EV/FCF
252 251 224 288 580 737 136 328 849 704
Op' Cash Flow
(14) (8) (7) (21) (14) (9) (51) (67) (40) (22)
Capex
238 243 218 267 566 728 86 262 809 682
FCF
(22) (145) (111) (8) 171 (163) 35 114 154 205
Working Cap'
33 12 9 5 1 1 343 — — —
Total Debt
(460) (288) (277) (376) (846) (834) (372) (722) (971) (1,189)
Net Debt
727 853 891 984 1,384 1,444 1,613 1,837 2,175 2,342
Sh' Equity
8.82% 12.29% 11.19% 11.85% 15.25% 16.48% 8.68% 9.13% 11.44% 10.47%
ROA
42.68% 23.74% 22.31% 23.59% 47.49% 62.78% 17.20% 20.92% 26.09% 28.57%
ROIC
15.73% 21.82% 18.24% 19.60% 26.42% 30.97% 16.63% 16.25% 19.93% 18.85%
ROE
predictions in italic, sparklines do not include predictions

All 10 years →

Fiscal years to Mar 2026 · latest quarter Jun 2026

Houlihan Lokey, Inc. peers in Capital Markets

All 93 Capital Markets stocks →

Houlihan Lokey, Inc. (HLI) key facts

  • Houlihan Lokey, Inc. (HLI) is a Capital Markets company in the Financial sector, listed on the New York Stock Exchange.
  • Houlihan Lokey, Inc.’s revenue for fiscal 2026 (year ended March 2026) was $2.6 billion, up 9.55% from fiscal 2025.
  • Net income was $424.2 million, or $6.40 per share (basic), a net margin of 16.3%.
  • As of September 25, 2026, HLI traded at $129.07, a market capitalization of $8.9 billion.
  • At that price the stock trades at 21.2× trailing-twelve-month earnings and 3.4× sales.
  • Houlihan Lokey, Inc. pays an annual dividend of $2.20 per share, a yield of 1.76%, with a payout ratio of 59.0%.
  • Return on equity was 18.9% and debt-to-equity 0.00.

Source: company filings (standardised) and stockrow calculations.

Houlihan Lokey, Inc. (HLI) Latest News

News by impact score

Fine-tune

22 Sep

3

Houlihan Lokey named Prabha Sipi Bhandari Chief Legal Officer, overseeing global legal and compliance and serving as corporate secretary and an Executive Officer. She succeeds Christopher Crain, who becomes Corporate Senior Advisor during the transition. Bhandari previously served as CLO, Chief Ethics Officer, and Secretary at Paychex, and held senior legal roles at AIG, Freddie Mac, Viacom, and 13 years at Deutsche Bank (Managing Director, General Counsel for Deutsche Bank Securities Inc., Global Head of M&A – Legal). She began her career at Davis Polk and clerked for the Fifth Circuit. She holds a B.S. from Cornell and a J.D. from NYU. CEO Scott Adelson praised her deep experience in M&A, governance, and regulatory matters as the firm grows globally. Crain will assist with the transition and later advise on non-legal matters. Bhandari’s global legal leadership could strengthen governance and risk management during Houlihan Lokey’s expansion, with potential mid-term benefits to performance.

16 Sep

4

Houlihan Lokey is expanding into GP-led secondaries to capture growth in private equity secondary markets amid rising demand for liquidity solutions. Strategic entry into GP-led secondaries represents a major move that could significantly boost revenue streams and competitive positioning.

11 Sep

3

Houlihan Lokey indicates growing financial difficulties among smaller private-credit borrowers. Rising stress among private-credit borrowers signals potential growth in restructuring advisory demand.

10 Sep

3

Stress among the smallest private credit borrowers has climbed more than tenfold since 2023 according to Houlihan Lokey findings. Rising small-borrower stress signals potential growth in Houlihan Lokey's private-credit advisory and restructuring mandates.

24 Aug

3

Houlihan Lokey reports Q2 earnings and faces buy, sell or hold analysis for its stock. Q2 earnings review can shift near-term investor sentiment and trading around HLI.

7 Aug

3 transcript

Houlihan Lokey (HLI) held its Q1 2027 earnings call covering financial results, performance metrics and forward outlook. Earnings call supplies quarterly results and guidance that can shift near-term valuation and sentiment.

3 Aug

4

Houlihan Lokey and Barclays lead financial services M&A advisory rankings for H1 2026. Top M&A advisory ranking directly strengthens Houlihan Lokey's deal pipeline and revenue outlook.

1 Aug

4

Houlihan Lokey (HLI) leads North American M&A deal volume in H1 2026. Leading regional M&A volume boosts Houlihan Lokey's reputation and deal pipeline.

30 Jul

3 transcript

Houlihan Lokey reported Q1 revenue of $514 million, up 25% year-over-year, with adjusted EPS at $1.45. Corporate finance and financial restructuring segments drove growth amid active M&A and debt markets. Management highlighted strong backlog and expects continued momentum into fiscal 2025. Quarterly results and guidance update investor views on near-term revenue and margins but do not signal structural change.

29 Jul

3

Houlihan Lokey (HLI) Q1 earnings show key metrics versus Wall Street estimates. Q1 earnings metric comparisons may affect short-term stock price movements.

3

Houlihan Lokey reported first quarter fiscal 2027 financial results. Quarterly earnings release supplies performance metrics that can shift near-term investor views without altering long-term strategy.

22 Jul

3

Analysts forecast Houlihan Lokey (HLI) will post lower earnings, flagging items investors should monitor ahead of the report. Expected earnings drop may pressure near-term stock price and investor sentiment.

1 Jul

4

Houlihan Lokey acquires Intrepid to expand energy advisory operations and capture sector growth. Acquisition of Intrepid represents major strategic expansion in energy advisory that strengthens competitive position and growth outlook.

30 Jun

4

Houlihan Lokey, Inc. (HLI) acquires Intrepid Financial Partners in a strategic expansion of its financial advisory and investment banking operations. Acquisition marks a major strategic move that expands Houlihan Lokey's platform and competitive reach.

24 Jun

3

Morningstar Indexes and Houlihan Lokey will launch a daily valued index suite for the Collateralized Loan Obligation market. New CLO index suite launch with Morningstar expands Houlihan Lokey's product offerings and market positioning in financial services.

4 Jun

3

Houlihan Lokey hires senior executive in Capital Solutions Group to expand GP-led secondaries capabilities into real estate. Single senior hire supports targeted expansion of secondaries platform into adjacent real estate segment.

3 Jun

4

Houlihan Lokey, Inc. (HLI) has three reasons supporting explosive upside potential. Three reasons for explosive upside indicate significant future performance gains for HLI.

2 Jun

3

GA Group launches dedicated Transaction Opinions Practice with elite leadership team to accelerate advisory expansion. Launch of specialized transaction opinions unit expands advisory capacity and competitive reach in financial services.

16 May

3

Houlihan Lokey’s Q1 earnings call highlighted five key analyst questions on financial performance, market conditions and strategic outlook. Earnings call insights may moderately shift short-term investor views on Houlihan Lokey’s results and guidance.

14 May

3

UBS trims price target on Houlihan Lokey (HLI) as the firm enters fiscal 2027 with a cautious outlook. UBS price target cut highlights cautious expectations for HLI's fiscal 2027 performance, impacting market sentiment moderately.

10 May

4

Houlihan Lokey reported Q4 earnings call highlights, covering financial results, revenue growth, deal activity, and outlook amid market challenges. Q4 earnings highlights detail financial performance and guidance that significantly shape HLI's stock trajectory and investor sentiment.

8 May

3

Houlihan Lokey, Inc. (HLI) missed EPS estimates by 9.3%. Analysts forecast future performance amid the earnings shortfall. EPS miss of 9.3% directly impacts financial results and could moderately affect stock sentiment and trajectory.

7 May

4 transcript

Houlihan Lokey (HLI) released Q4 2026 earnings call transcript detailing quarterly financial results, management discussion, and future outlook. Q4 earnings transcripts disclose critical financial metrics and guidance that drive significant shifts in investor sentiment and stock trajectory.

4

Houlihan Lokey, Inc. released Q4 2026 earnings call summary detailing financial results, strategic updates, and outlook. Q4 earnings call summary discloses financial performance and guidance, significantly impacting investor sentiment and stock trajectory.

6 May

4

Houlihan Lokey, Inc. (HLI) reported fiscal year and fourth quarter 2026 financial results. Fiscal year-end and quarterly earnings reports significantly impact HLI's financial performance perception and stock trajectory.

3

Houlihan Lokey (HLI) Q4 earnings key metrics compared to analyst estimates. Q4 earnings metrics versus estimates moderately influence HLI's financial performance perception and short-term market sentiment.

3

Houlihan Lokey (HLI) missed Q4 earnings and revenue estimates. Missing quarterly earnings and revenue estimates impacts financial performance and investor sentiment but is limited to one quarter.

3

Houlihan Lokey (NYSE:HLI) missed Q1 CY2026 revenue estimates. Missing Q1 CY2026 revenue estimates signals weaker financial performance, likely causing moderate short-term pressure on stock price and investor sentiment.

29 Apr

3

Houlihan Lokey, Inc. (HLI) Q4 earnings expected to decline ahead of report release. Expected Q4 earnings decline signals moderately noticeable pressure on financial performance and investor sentiment.

21 Apr

4

Goldman Sachs and Houlihan Lokey topped the M&A advisers list in Q1 2026. Topping the M&A advisers list alongside Goldman Sachs boosts HLI's reputation, deal pipeline, and investor sentiment significantly.

stockrow.com/HLI · Data as of Jun 30, 2026 · For information only; not investment advice. · © 2026 stockrow.com